Login / Signup

Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder.

Masaki KatoToshiaki KikuchiKoichiro WatanabeTomiki SumiyoshiYoshiya MoriguchiDaniel Oudin ÅstrømMichael Cronquist Christensen
Published in: Neuropsychiatric disease and treatment (2024)
The results of this open-label study support the use of the GAS-D as a valid and sensitive outcome measure in the assessment of treatment response in MDD.
Keyphrases
  • major depressive disorder
  • bipolar disorder
  • open label
  • room temperature
  • clinical trial
  • depressive symptoms
  • phase ii
  • squamous cell carcinoma
  • carbon dioxide
  • phase iii
  • sleep quality
  • phase ii study